Women much more likely to develop AFib after a breast cancer diagnosis The analysis included data from more than 85,000 breast cancer patients and an equal number of healthy women with no history of breast cancer. Read more about Women much more likely to develop AFib after a breast cancer diagnosis
Empagliflozin provides consistent benefits for HFpEF patients Researchers took a fresh look at data from the EMPEROR-Preserved trial, sharing their findings in Circulation.Read more about Empagliflozin provides consistent benefits for HFpEF patients
FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra All pacemakers are associated with a risk of cardiac perforation, the agency said, but perforation-related complications appear to be more severe with leadless pacing systems.Read more about FDA highlights safety issue with leadless pacemakers, focusing on Medtronic’s Micra
New study of more than 4.5M patients examines how blood pressure can impact the risk of dementia Researchers said they hope their findings can shine new light on this "complex relationship."Read more about New study of more than 4.5M patients examines how blood pressure can impact the risk of dementia
PAD specialists announce new FDA clearance for image-guided atherectomy system The solution is now cleared as a treatment option for in-stent restenosis in the lower extremity arteries.Read more about PAD specialists announce new FDA clearance for image-guided atherectomy system
Patient frailty not a key factor when choosing between TAVR and SAVR Frailty measurements may still provide helpful information in other ways, of course. Read more about Patient frailty not a key factor when choosing between TAVR and SAVR
PCI and CABG for left main CAD associated with similar all-cause mortality rates Researchers examined data from the SYNTAX, PRECOMBAT, NOBLE and EXCEL trials, sharing their findings in The Lancet.Read more about PCI and CABG for left main CAD associated with similar all-cause mortality rates
What new research tells us about TAVR and platelet-to-lymphocyte ratios The blood-based biomarker was previously associated with worse acute coronary syndrome outcomes. What does it mean for TAVR patients?Read more about What new research tells us about TAVR and platelet-to-lymphocyte ratios
Stem cell therapy for heart failure lowers risk of adverse outcomes “Cell therapy has the potential to change how we treat heart failure,” one researcher said. Read more about Stem cell therapy for heart failure lowers risk of adverse outcomes
Cardiologs puts its AI model up against the Apple Watch—and wins The company reported that its deep neural network led to improved sensitivity and fewer unclassified findings. Read more about Cardiologs puts its AI model up against the Apple Watch—and wins
